Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Marrocco

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Science Signaling|June 23, 2021
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasisMary L Uribe, Maik Dahlhoff, Rajbir N Batra, et al.
Cancers|August 28, 2020
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase InhibitorDonatella Romaniello, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
The Journal of Biological Chemistry|May 17, 2021
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activationDaniela Ricci, Stephen Tutton, Ilaria Marrocco, et al.
Journal of Autoimmunity|May 24, 2023
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseasesLaura Passeri, Grazia Andolfi, Virginia Bassi, et al.
Cell Reports|October 3, 2019
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing SarcomaSwati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Science Signaling|June 23, 2021
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasisMary L Uribe, Maik Dahlhoff, Rajbir N Batra, et al.
Cancers|August 28, 2020
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase InhibitorDonatella Romaniello, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
The Journal of Biological Chemistry|May 17, 2021
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activationDaniela Ricci, Stephen Tutton, Ilaria Marrocco, et al.
Journal of Autoimmunity|May 24, 2023
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseasesLaura Passeri, Grazia Andolfi, Virginia Bassi, et al.
Cell Reports|October 3, 2019
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing SarcomaSwati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar, et al.
Pageof 3